3.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Eledon Pharmaceuticals Inc Borsa (ELDN) Ultime notizie
Eledon to present kidney transplant rejection drug results at ASN meeting - Investing.com Australia
Eledon Pharmaceuticals to Present Phase 2 BESTOW Trial Results on Tegoprubart at Kidney Week 2025 - Quiver Quantitative
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting - Stock Titan
Using RSI to spot recovery in Eledon Pharmaceuticals Inc.Weekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
Will Eledon Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Reactions & Safe Capital Preservation Plans - newser.com
Quantitative breakdown of Eledon Pharmaceuticals Inc. recent moveTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
Published on: 2025-10-15 10:55:31 - newser.com
Has Eledon Pharmaceuticals Inc. found a price floor2025 Volatility Report & Verified Entry Point Signals - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock trades below fair valueMarket Movers & Safe Entry Point Alerts - newser.com
Published on: 2025-10-15 04:48:47 - newser.com
Published on: 2025-10-14 22:55:26 - newser.com
Key metrics from Eledon Pharmaceuticals Inc.’s quarterly dataEntry Point & AI Forecasted Entry/Exit Points - newser.com
Evaluating Eledon Pharmaceuticals Inc. with trendline analysisJuly 2025 Highlights & Safe Swing Trade Setup Alerts - newser.com
Will Eledon Pharmaceuticals Inc. stock return to pre crisis levelsJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Is Eledon Pharmaceuticals Inc. forming a bottoming baseWeekly Gains Summary & Daily Stock Trend Watchlist - newser.com
Is Eledon Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Published on: 2025-10-13 09:50:08 - newser.com
What risks investors should watch in Eledon Pharmaceuticals Inc. stock2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Using R and stats models for Eledon Pharmaceuticals Inc. forecastingEarnings Recap Summary & AI Enhanced Trading Alerts - newser.com
Why analysts remain bullish on Eledon Pharmaceuticals Inc. stockWeekly Trade Report & Weekly Hot Stock Watchlists - newser.com
Eledon Pharmaceuticals Inc. stock chart pattern explainedJobs Report & Daily Entry Point Alerts - newser.com
Real time pattern detection on Eledon Pharmaceuticals Inc. stockJuly 2025 Weekly Recap & Low Risk High Reward Trade Ideas - newser.com
Has Eledon Pharmaceuticals Inc. formed a bullish divergenceTrade Exit Summary & Community Consensus Trade Signals - newser.com
How strong is Eledon Pharmaceuticals Inc. (2TK) stock earnings growthJuly 2025 Outlook & High Accuracy Trade Alerts - newser.com
Eledon Pharmaceuticals' (ELDN) "Sell (D)" Rating Reiterated at Weiss Ratings - MarketBeat
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance
Eledon Pharmaceuticals Inc. stock trend outlook and recovery pathLong Setup & Safe Capital Growth Stock Tips - newser.com
What technical models suggest about Eledon Pharmaceuticals Inc.’s comebackQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Is Eledon Pharmaceuticals Inc 2TK a good long term investmentStock Rotation Strategies & Superior Portfolio Growth - earlytimes.in
Published on: 2025-10-06 03:44:24 - newser.com
What technical patterns form on Eledon Pharmaceuticals Inc. (2TK) stock chartsJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Can you recover from losses in Eledon Pharmaceuticals Inc.July 2025 Update & Free Real-Time Market Sentiment Alerts - newser.com
Using data tools to time your Eledon Pharmaceuticals Inc. exitPortfolio Risk Summary & Entry and Exit Point Strategies - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock inflation resilientJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - newser.com
Will Eledon Pharmaceuticals Inc. (2TK) stock keep raising dividendsDay Trade & Weekly Breakout Watchlists - newser.com
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):